457 related articles for article (PubMed ID: 23375981)
21. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
Tofteland S; Dahl KH; Aasnæs B; Sundsfjord A; Naseer U
Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
[TBL] [Abstract][Full Text] [Related]
22. SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae.
Szabó D; Bonomo RA; Silveira F; Pasculle AW; Baxter C; Linden PK; Hujer AM; Hujer KM; Deeley K; Paterson DL
J Clin Microbiol; 2005 Oct; 43(10):5058-64. PubMed ID: 16207962
[TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to cefotaxime, ceftazidime, cefepime and aztreonam.
Cheng NC; Liu CY; Huang YT; Liao CH; Teng LJ; Hsueh PR
J Antimicrob Chemother; 2012 Jun; 67(6):1413-21. PubMed ID: 22345386
[TBL] [Abstract][Full Text] [Related]
24. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of extended-spectrum beta-lactamases in isolates of the Enterobacter cloacae complex from German hospitals.
Hoffmann H; Stürenburg E; Heesemann J; Roggenkamp A
Clin Microbiol Infect; 2006 Apr; 12(4):322-30. PubMed ID: 16524408
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.
Udomsantisuk N; Nunthapisud P; Tirawatanapong T; Dansuputra M
J Med Assoc Thai; 2011 Dec; 94(12):1504-12. PubMed ID: 22295740
[TBL] [Abstract][Full Text] [Related]
27. Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan.
Yu WL; Cheng KC; Chi CJ; Chen HE; Chuang YC; Wu LT
Clin Microbiol Infect; 2006 Jun; 12(6):579-82. PubMed ID: 16700709
[TBL] [Abstract][Full Text] [Related]
28. Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. Hospitals.
Castanheira M; Doyle TB; Mendes RE; Sader HS
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085510
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
[TBL] [Abstract][Full Text] [Related]
30. What does the susceptible-dose dependent interpretive category for cefepime in ESBL-producing bacteria?
Menegucci TC; Bastos MS; Viana GF; Moreira RRB; Garcia LB; Cardoso CL; Tognim MCB
J Chemother; 2017 Jun; 29(3):189-194. PubMed ID: 27077929
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and molecular characterization of extended-spectrum β-lactamases and AmpC β-lactamases in Klebsiella pneumoniae.
Al-Agamy MH
Pak J Pharm Sci; 2013 Mar; 26(2):291-8. PubMed ID: 23455199
[TBL] [Abstract][Full Text] [Related]
32. [The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility].
She D; Liu Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1355-8. PubMed ID: 12509943
[TBL] [Abstract][Full Text] [Related]
33. Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species.
Kohner PC; Robberts FJ; Cockerill FR; Patel R
J Clin Microbiol; 2009 Aug; 47(8):2419-25. PubMed ID: 19494061
[TBL] [Abstract][Full Text] [Related]
34. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran.
Feizabadi MM; Delfani S; Raji N; Majnooni A; Aligholi M; Shahcheraghi F; Parvin M; Yadegarinia D
Microb Drug Resist; 2010 Mar; 16(1):49-53. PubMed ID: 19961397
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and characterization of extended spectrum beta-lactamase-producing Enterobacter cloacae strains in Algeria.
Nedjai S; Barguigua A; Djahmi N; Jamali L; Zerouali K; Dekhil M; Timinouni M
J Infect Dev Ctries; 2013 Nov; 7(11):804-11. PubMed ID: 24240037
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
37. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
Ensor VM; Shahid M; Evans JT; Hawkey PM
J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
[TBL] [Abstract][Full Text] [Related]
39. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Martinez P; Garzón D; Mattar S
Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
[TBL] [Abstract][Full Text] [Related]
40. The molecular characteristics of cefepime-susceptible Escherichia coli and Klebsiella spp. isolates with a positive β-lactamase screening test result but negative confirmation.
Hu F; Wu W; Ye X; Xu X; Zhu D
Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1297-9. PubMed ID: 20549530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]